Jellinger K A, Stadelmann C
Ludwig Boltzmann Institute of Clinical Neurobiology, Psychiatric Hospital, Vienna, Austria.
J Neural Transm Suppl. 2000;59:95-114. doi: 10.1007/978-3-7091-6781-6_13.
Progressive cell loss in specific neuronal populations is the prominent pathological hallmark of neurodegenerative diseases, but its molecular basis remains unresolved. Apoptotic cell death has been implicated as a general mechanism in Alzheimer disease (AD) and other neurodegenerative disorders. However, DNA fragmention in neurons is too frequent to account for the continuous loss in these slowly progressive diseases.
In 9 cases of morphologically confirmed AD (CERAD criteria, Braak stages 5 or 6), 5 cases of Parkinson disease (PD) and 3 cases each of Dementia with Lewy bodies (DLB), Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA), and 7 age-matched controls, the TUNEL method was used to detect DNA fragmentation, and immunohistochemistry for an array of apoptosis-related proteins (ARP), protooncogenes, and activated caspase-3 were performed.
In AD, a considerable number of hippocampal neurons showed DNA fragmentation with a 3 to 5.7 fold increase related to neurofibrillary tangles and amyloid deposits, but only exceptional neurons displayed apoptotic morphology (1 in 1100-5000) and cytoplasmic immunoreactivity for ARPs and activated caspase-3 (1 in 2600 to 5650 hippocampal neurons), whereas no neurons were labeled in age-matched controls. Caspase-3 immunoreactivity was seen in granules of granulovacuolar degeneration, only rarely colocalized with tau-immunoreactivity. In PD, DLB, and MSA, TUNEL positivity and expression of ARPs or activated caspase-3 was only seen in microglia, rare astrocytes and in oligodendroglia with cytoplasmic inclusions in MSA, but not in nigral or other neurons with or without Lewy bodies. In PSP, only single neurons but oligodendrocytes, some with tau deposits, in brainstem tegmentum and pontine nuclei were TUNEL-positive and expressed both ARPs and activated caspase-3.
These data provide evidence for extremely rare apoptotic neuronal death in AD compatible with the progression of neuronal degeneration in this chronic disease. In other neurodegenerative disorders, apoptosis mainly involves microglia and oligodendroglia, while alternative mechanisms of neuronal death may occur. Susceptible cell populations in a proapoptotic environment show increased vulnerability towards metabolic and other pathogenic factors, with autophagy as a possible protective mechanism in early stages of programmed cell death. The intracellular cascade leading to cell death still awaits elucidation.
特定神经元群体中细胞的渐进性丢失是神经退行性疾病的显著病理标志,但其分子基础仍未明确。凋亡性细胞死亡被认为是阿尔茨海默病(AD)及其他神经退行性疾病的一种普遍机制。然而,神经元中的DNA片段化过于频繁,无法解释这些缓慢进展性疾病中细胞的持续丢失。
对9例形态学确诊的AD(CERAD标准,Braak分期5或6期)、5例帕金森病(PD)、3例路易体痴呆(DLB)、进行性核上性麻痹(PSP)和多系统萎缩(MSA)患者以及7例年龄匹配的对照者,采用TUNEL法检测DNA片段化,并进行一系列凋亡相关蛋白(ARP)、原癌基因和活化的半胱天冬酶-3的免疫组织化学检测。
在AD中,相当数量的海马神经元显示DNA片段化,与神经原纤维缠结和淀粉样沉积相关,增加了3至5.7倍,但只有极少数神经元呈现凋亡形态(1100 - 5000个中有1个)以及对ARP和活化的半胱天冬酶-3的细胞质免疫反应性(2600至5650个海马神经元中有1个),而在年龄匹配的对照者中未发现神经元被标记。半胱天冬酶-3免疫反应性见于颗粒空泡变性的颗粒中,仅很少与tau免疫反应性共定位。在PD、DLB和MSA中,可以见到TUNEL阳性以及ARP或活化的半胱天冬酶-3的表达,仅见于小胶质细胞、罕见的星形胶质细胞以及MSA中有细胞质包涵体的少突胶质细胞中,而在有或没有路易小体的黑质或其他神经元中未见。在PSP中,仅脑干被盖和脑桥核中的单个神经元以及一些有tau沉积的少突胶质细胞TUNEL阳性,并同时表达ARP和活化的半胱天冬酶-3。
这些数据为AD中极其罕见的凋亡性神经元死亡提供了证据,这与该慢性疾病中神经元变性的进展相一致。在其他神经退行性疾病中,凋亡主要涉及小胶质细胞和少突胶质细胞,而可能存在神经元死亡的其他机制。处于促凋亡环境中的易感细胞群体对代谢和其他致病因素的易损性增加,自噬可能是程序性细胞死亡早期阶段的一种保护机制。导致细胞死亡的细胞内级联反应仍有待阐明。